Ishita Drugs & Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve 1. To consider, approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ishita Drugs & Industries Ltd has informed BSE about a Board Meeting scheduled for 30th May 2026. The meeting will consider and approve the Audited Financial Results for the quarter and year ended 31st March 2026. Additionally, the Board will consider the Directors' Report, Corporate Governance Report, Management Discussion and Analysis Report, and Notice for the 33rd Annual General Meeting. The meeting also includes agenda items for re-appointment of Internal Auditors for 2026-27 and taking on record Disclosure of Interest of Directors. The trading window for insiders has been closed from 1st April 2026 until 48 hours after the announcement of results.
This is a routine board meeting notice for annual results approval. The actual impact on the stock will depend on the financial results to be announced after the meeting. Investors should watch for the Q4/FY2026 results announcement expected shortly after 30th May 2026.